Pharmaleaders TV
You are here:  / Breaking News / Business / Dr. Reddy’s opts for AWS as preferred cloud provider to develop affordable pharma therapies for patients worldwide

Dr. Reddy’s opts for AWS as preferred cloud provider to develop affordable pharma therapies for patients worldwide

Amazon Web Services (AWS), an Amazon.com company, has announced that Dr. Reddy’s Laboratories selected it as a preferred cloud provider to help provide access to affordable and innovative medicines.

As part of the collaboration, the company has migrated its SAP platform entirely on to AWS. By centralizing the platform on the world’s leading cloud, Dr. Reddy’s will accelerate the development of new healthcare applications, grow its digital platform to help the organization serve more than 1.5 billion patients by 2030 around the world, and enable healthcare providers to better track the progress of patients.

Since 2019, Dr. Reddy’s has been progressively creating and migrating digital applications to AWS to automate the company’s IT infrastructure. With AWS, Dr. Reddy’s aims to reduce application development time by 30%, improve internal operations, accelerate improvements in generic drug manufacturing processes, and drive new areas of innovation. The company is one of the first AWS customers to run its data centre and disaster recovery workloads now from both the new AWS Asia Pacific (Hyderabad) Region and the AWS Asia Pacific (Mumbai) Region.

“Working with AWS gives us access to the best-in-class technology innovation, enabling us in our vision to provide affordable healthcare to patients in nearly 70 countries,” said Mukesh Rathi, chief information and digital officer at Dr. Reddy’s.

“The reliability of AWS helps us accelerate the delivery of high-quality digital products, allowing us to transform customer service, and help us to deliver on our sustainability goals by making our supply chains greener,” he added.

“In addition to the cloud migration and modernization efforts with AWS, Dr. Reddy’s and Amazon have entered into a strategic collaboration to build innovative go-to-market models to help fuel long-term growth,” said M V Ramana, CEO, branded markets (India & Emerging Markets), Dr. Reddy’s.

“AWS’s proven expertise in supporting healthcare customers globally, coupled with our breadth of cloud technologies and global infrastructure, empowers Dr. Reddy’s to create differentiated customer and patient experiences while reducing the environmental footprint of their IT operations,” said Vaishali Kasture, director of AWS India and South Asia at Amazon Web Services India Pvt. Ltd

AWS recently announced its plans to invest Rs. 1,05,600 crore (US$ 12.7 billion) into cloud infrastructure in India by 2030 to meet growing customer demand for cloud services in India. This investment is estimated to contribute Rs. 1,94,700 crore to India’s total gross domestic product (GDP) by 2030, said the company.

PHARMALEADERS

Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.

Follow us
Contact us

Network 7 Meadia Group

Plot 5, NS Road No. 12, JVPD, Juhu Scheme, Mumbai, Maharashtra 400049. editorial@pharmaleaders.tv